The JN.1 variant, previously part of the BA.2.86 sub-lineage, has seen a rapid rise globally, prompting extra precautions during the winter, when respiratory infections like Covid-19 are more prevalent.
India s toxic syrup bribery probe nears completion - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
India is close to finishing an investigation into a complaint that a state drug regulator helped switch samples of cough syrups linked to the deaths of children in Gambia before they were tested in India. The World Health Organization (WHO) linked the syrups made by India s Maiden Pharmaceuticals to the deaths of 70 children in the African country last year. India s government says tests at an Indian government laboratory showed the syrups were not toxic.
India is close to finishing an investigation into a "comprehensive and exhaustive" complaint that a state drug regulator, in return for a bribe, helped switch samples of cough syrups linked to the deaths of children in Gambia before the samples were tested in India, the investigator told Reuters. While the World Health Organization (WHO) linked the syrups made by India's Maiden Pharmaceuticals to the deaths of 70 children in the African country last year, India's government says tests at an Indian government laboratory showed the syrups were not toxic. Reuters reported in June that in an April 29 letter to the Anti-Corruption Bureau in Haryana state, where Maiden has its factory, a lawyer named Yashpal accused the state's drug controller, Manmohan Taneja, of taking a bribe of 50 million rupees ($600,687) from Maiden to help switch the samples before they went for tests at the government laboratory.